The U.S. Food and Drug Administration (FDA) has issued a warning about the use of unapproved devices for diabetes management, so-called “DIY” diabetes management devices that include continuous glucose monitoring systems, insulin pumps, and automated insulin dosing systems. The agency noted that the use of unapproved or unauthorized devices could result in inaccurate blood glucose measurements or …